Medicare Enrolled

Dr. Lucas McCaffrey, DO

Rheumatology · Riverhead, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
889 E MAIN ST STE 308, Riverhead, NY 11901
6313863500
In practice since 2012 (14 years)
NPI: 1891050290 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McCaffrey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCaffrey? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McCaffrey

Dr. Lucas McCaffrey is a rheumatology specialist in Riverhead, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. McCaffrey performed 5,494 Medicare services across 1,219 unique beneficiaries.

Between the years covered by Open Payments, Dr. McCaffrey received a total of $11,646 from 35 pharmaceutical and/or device companies across 666 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McCaffrey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 24% volume in NY $11,646 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,494
Medicare services
Top 24% in NY for rheumatology
1,219
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~392 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,360 $19 $50
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
771 $107 $550
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
535 $8 $21
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
236 $76 $375
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
195 $144 $997
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
155 $13 $275
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
129 $60 $434
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
61 $64 $1,323
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
27 $101 $560
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
25 $9 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
65.5% medium
32.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,646
Total received (2018-2024)
Avg $1,664/year across 7 years
Top 25% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
666
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,229 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$418 (3.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,086
2023
$769
2022
$1,846
2021
$2,314
2020
$1,387
2019
$2,310
2018
$1,934

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$324
PFIZER INC.
$254
Novartis Pharmaceuticals Corporation
$194
Amgen Inc.
$113
Janssen Biotech, Inc.
$64
UCB, Inc.
$46
E.R. Squibb & Sons, L.L.C.
$36
Lilly USA, LLC
$27
Amneal Pharmaceuticals LLC
$27
Top 3 companies account for 71.1% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$1,994
Amgen Inc.
$1,788
Horizon Therapeutics plc
$819
AbbVie Inc.
$778
UCB, Inc.
$761
ABBVIE INC.
$744
Lilly USA, LLC
$687
GlaxoSmithKline, LLC.
$667
Genentech USA, Inc.
$542
Novartis Pharmaceuticals Corporation
$439
Mallinckrodt LLC
$314
AbbVie, Inc.
$256
AstraZeneca Pharmaceuticals LP
$243
Mallinckrodt Enterprises LLC
$154
Hikma Pharmaceuticals USA
$153
Radius Health, Inc.
$148
MEDAC PHARMA, INC.
$125
Mallinckrodt Hospital Products Inc.
$122
Gilead Sciences, Inc.
$115
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
Merck Sharp & Dohme Corporation
$95
E.R. Squibb & Sons, L.L.C.
$81
Celgene Corporation
$77
FIDIA PHARMA USA INC.
$74
Janssen Biotech, Inc.
$64
Ferring Pharmaceuticals Inc.
$55
MEDEXUS PHARMA, INC.
$49
Aurinia Pharma U.S., Inc.
$40
Regeneron Healthcare Solutions, Inc.
$32
Amneal Pharmaceuticals LLC
$27
GENZYME CORPORATION
$22
Daiichi Sankyo Inc.
$21
West-Ward Pharmaceuticals
$21
Horizon Pharma plc
$19
SANOFI-AVENTIS U.S. LLC
$18
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · COSENTYX · Cimzia · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · HYALGAN · Humira · Hymovis · INFLECTRA · INJECTAFER · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · OFEV · ORENCIA · Otezla · PENNSAID · Prolia · RAYOS · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SKYRIZI · TALTZ · TREMFYA · Tavneos · Tymlos · UNITHROID · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Riverhead?
Compare rheumatologists in the Riverhead area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
13
Per 100K population
0.9
County median income
$128,329
Nearest hospital
PECONIC BAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McCaffrey is a clinical cardiology specialist, with above-average Medicare volume (top 24% in NY), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McCaffrey experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. McCaffrey performed 3,360 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McCaffrey receive payments from pharmaceutical companies?
Yes. Dr. McCaffrey received a total of $11,646 from 35 companies across 666 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCaffrey's costs compare to other rheumatologists in Riverhead?
Dr. McCaffrey's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCaffrey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →